Psoriasis-associated itch: etiology, assessment, impact, and management

References

• Globe D, Bayliss MS, Harrison DJ. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes. 2009;7:62.
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat. 2002;10:221–226.
   PubMedGoogle Scholar
• Potenzieri C, Undem BJ. Basic mechanisms of itch. Clin Exp Allergy. 2012;42:8–19.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ. Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations. Dan Med Bull. 1991;38:478–480.
   PubMedGoogle Scholar
• Petersen LJ, Hansen U, Kristensen JK, et al. Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm Venereol. 1998;78:190–193.
   PubMed Web of Science ®Google Scholar
• Wiśnicka B, Szepietowski JC, Reich A, et al. Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatol Psychosom. 2004;5:73–78.
   Google Scholar
• Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149:718–730.
   PubMed Web of Science ®Google Scholar
• Peres LP, Oliveira FB, Cartell A, et al. Density of mast cells and intensity of pruritus in psoriasis vulgaris: a cross sectional study. An Bras Dermatol. 2018;93:368–372.
   PubMed Web of Science ®Google Scholar
• Naukkarinen A, Nickoloff BJ, Farber EM. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol. 1989;92:126–129.
   PubMed Web of Science ®Google Scholar
• Eedy DJ, Johnston CF, Shaw C, et al. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol. 1991;96:434–438.
   PubMed Web of Science ®Google Scholar
• Amatya B, El-Nour H, Holst M, et al. Expression of tachykinins and their receptors in plaque psoriasis with pruritus. Br J Dermatol. 2011;164:1023–1029.
   PubMed Web of Science ®Google Scholar
• Gupta K, Harvima IT. Mast cell-neural interactions contribute to pain and itch. Immunol Rev. 2018;282:168–187.
   PubMed Web of Science ®Google Scholar
• Andoh T, Nagasawa T, Satoh M. Substance P induction of itch‐associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther. 1998;286:1140–1145.
   PubMed Web of Science ®Google Scholar
• Reich A, Orda A, Wiśnicka B, et al. Plasma neuropeptides and perception of pruritus in psoriasis. Acta Derm Venereol. 2007;87:299–304.
   PubMed Web of Science ®Google Scholar
• Remröd C, Lonne-Rahm S, Nordlind K. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus. Arch Dermatol Res. 2007;299:85–91.
   PubMed Web of Science ®Google Scholar
• Wilson SR, Nelson AM, Batia L, et al. The ion channel TRPA1 is required for chronic itch. J Neurosci. 2013;33:9283–9294.
   PubMed Web of Science ®Google Scholar
• Kodji X, Arkless KL, Kee Z, et al. Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis. Faseb J. 2019;33:1578–1594.
   PubMed Web of Science ®Google Scholar
• Nigam R, El-Nour H, Amatya B, et al. GABA and GABA(A) receptor expression on immune cells in psoriasis: a pathophysiological role. Arch Dermatol Res. 2010;302:507–515.
   PubMed Web of Science ®Google Scholar
• Sakai K, Sanders KM, Youssef MR, et al. Role of neurturin in spontaneous itch and increased nonpeptidergic intraepidermal fiber density in a mouse model of psoriasis. Pain. 2017;158:2196–2202.
   PubMed Web of Science ®Google Scholar
• Wong LS, Otsuka A, Yamamoto Y, et al. Vascular endothelial growth factor partially induces pruritus via epidermal hyperinnervation in imiquimod-induced psoriasiform dermatitis in mice. J Dermatol Sci. 2016;83:148–151.
   PubMed Web of Science ®Google Scholar
• Taneda K, Tominaga M, Negi O, et al. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch. Br J Dermatol. 2011;165:277–284.
   PubMed Web of Science ®Google Scholar
• Madej A, Reich A, Orda A, et al. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J Eur Acad Dermatol Venerol. 2007;21:72–78.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Tominaga M, Kosaka R, et al. Involvement of µ-opioid Receptors and κ-opioid Receptors in Itch-related Scratching Behaviour of Imiquimod-induced Psoriasis-like Dermatitis in Mice. Acta Derm Venerol. 2017;97:928–933.
   PubMed Web of Science ®Google Scholar
• Bigliardi PL, Tobin DJ, Gaveriaux-Ruff C, et al. Opioids and the skin-where do we stand? Exp Dermatol. 2009;18:424–430.
   PubMed Web of Science ®Google Scholar
• Reich A, Szepietowski JC. Mediators of pruritus in psoriasis. Mediators Inflamm. 2007;2007:64727.
   PubMed Web of Science ®Google Scholar
• Korman NJ, Zhao Y, Pike J, et al. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J. 2016;22(7).
   Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216.
   PubMed Web of Science ®Google Scholar
• Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707–713.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Mathias SD, Schenkel B, et al. Development of a patient-reported outcome questionnaire for use in adults with moderate to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary. J Dermatolog and Dermatolog Surg. 2016;20:19–26.
   Web of Science ®Google Scholar
• Mathias SD, Feldman SR, Crosby RD, et al. Measurement properties of a patient-reported outcome measure assessing psoriasis severity: the Psoriasis Symptoms and Signs Diary. J Dermatolog Treat. 2016;27:322–327.
   PubMed Web of Science ®Google Scholar
• Armstrong A, Puig L, Langley R, et al. Validation of psychometric properties and development of response criteria for the Psoriasis Symptoms and Signs Diary (PSSD): results from a phase III clinical trial. J Dermatolog Treat. 2019;30:27–34.
   PubMed Web of Science ®Google Scholar
• Gottlieb A, Feng J, Harrison DJ, et al. Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis. J Am Acad Dermatol. 2010;63:580–586.
   PubMed Web of Science ®Google Scholar
• Ständer S, Luger T, Cappelleri JC, et al. Validation of the itch severity item as a measurement tool for pruritus in patients with psoriasis: results from a Phase 3 Tofacitinib Program. Acta Derm Venereol. 2018;98:340–345.
   PubMed Web of Science ®Google Scholar
• Kimball AB, Naegeli AN, Edson-heredia E, et al. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2016;175:157–162.
   PubMed Web of Science ®Google Scholar
• Pedersen CB, Mchorney CA, Larsen LS, et al. Reliability and validity of the Psoriasis Itch Visual Analog Scale in psoriasis vulgaris. J Dermatolog Treat. 2017;28:213–220.
   PubMed Web of Science ®Google Scholar
• Reich A, Heisig M, Phan NQ, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92:497–501.
   PubMed Web of Science ®Google Scholar
• Erturk IE, Arican O, Omurlu IK, et al. Effect of the pruritus on the quality of life: a preliminary study. Ann Dermatol. 2012;24:406–412.
   PubMed Web of Science ®Google Scholar
• Elman S, Hynan LS, Gabriel V, et al. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162:587–593.
   PubMed Web of Science ®Google Scholar
• Reich A, Bożek A, Janiszewska K, et al. 12-Item Pruritus Severity Scale: development and validation of new itch severity questionnaire. Biomed Res Int. 2017;2017:3896423.
   PubMedGoogle Scholar
• Desai NS, Poindexter GB, Monthrope YM, et al. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008;59:234–244.
   PubMed Web of Science ®Google Scholar
• Stumpf A, Pfleiderer B, Fritz F, et al. Assessment of quality of life in chronic pruritus: relationship between ItchyQoL and Dermatological Life Quality Index in 1,150 patients. Acta Derm Venereol. 2018;98:142–143.
   PubMed Web of Science ®Google Scholar
• Steinke S, Zeidler C, Riepe C, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol. 2018;79:457–463.e5.
   PubMed Web of Science ®Google Scholar
• Majeski CJ, Johnson JA, Davison SN, et al. Itch Severity Scale: a self-report instrument for the measurement of pruritus severity. Br J Dermatol. 2007;156:667–673.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969–973.
   PubMed Web of Science ®Google Scholar
• Pithadia DJ, Reynolds KA, Lee EB, et al. Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management. J Dermatolog Treat. 2019;30:435–440.
   PubMed Web of Science ®Google Scholar
• Murray CS, Rees JL. Are subjective accounts of itch to be relied on? The lack of relation between visual analogue itch scores and actigraphic measures of scratch. Acta Derm Venereol. 2011;91:18–23.
   PubMed Web of Science ®Google Scholar
• Sanders KM, Akiyama T. The vicious cycle of itch and anxiety. Neurosci Biobehav Rev. 2018;87:17–26.
   PubMed Web of Science ®Google Scholar
• Remröd C, Sjöström K, Svensson Å. Pruritus in psoriasis: a study of personality traits, depression and anxiety. Acta Derm Venereol. 2015;95:439–443.
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Jo SJ, Naldi L, et al. A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey. Br J Dermatol. 2018;179:173–181.
   PubMed Web of Science ®Google Scholar
• Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venerol. 2010;90:257–263.
   PubMed Web of Science ®Google Scholar
• Lewis-Beck C, Abouzaid S, Xie L, et al. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling. Patient Prefer Adherence. 2013;7:199–205.
   PubMed Web of Science ®Google Scholar
• Amatya B, Wennersten G, Nordlind K. Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venerol. 2008;22:822–826.
   PubMed Web of Science ®Google Scholar
• Sampogna F, Abeni D, Gieler U, et al. Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries. Acta Derm Venerol. 2017;97:478–482.
   PubMed Web of Science ®Google Scholar
• Jensen P, Zachariae C, Skov L, et al. Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol. 2018;179:1376–1384.
   PubMedGoogle Scholar
• Kaaz K, Szepietowski JC, Matusiak Ł. Influence of itch and pain on sleep quality in atopic dermatitis and psoriasis. Acta Derm Venerol. 2019;99:175–180.
   PubMed Web of Science ®Google Scholar
• Boozalis E, Grossberg AL, Püttgen KB, et al. Itching at night: a review on reducing nocturnal pruritus in children. Pediatr Dermatol. 2018;35:560–565.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Penfold RB, Primatesta P, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;31:1168–1175.
   PubMed Web of Science ®Google Scholar
• Henry AL, Kyle SD, Chisholm A, et al. A cross-sectional survey of the nature and correlates of sleep disturbance in people with psoriasis. Br J Dermatol. 2017;177:1052–1059.
   PubMed Web of Science ®Google Scholar
• Kimball AB, Edson-heredia E, Zhu B, et al. Understanding the relationship between pruritus severity and work productivity in patients with moderate-to-severe psoriasis: sleep problems are a mediating factor. J Drugs Dermatol. 2016;15:183–188.
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Reich A. Itch in psoriasis management. Curr Probl Dermatol. 2016;50:102–110.
   PubMedGoogle Scholar
• Wu JJ, Lu M, Veverka KA, et al. Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States. J Dermatolog Treat. 2019;30:454–460.
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Stein Gold L, Cambazard F, et al. Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study. Eur J Dermatol. 2018;28:356–363.
   PubMed Web of Science ®Google Scholar
• Koo J, Tyring S, Werschler WP, et al. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris–a randomized phase II study. J Dermatolog Treat. 2016;27:120–127.
   PubMed Web of Science ®Google Scholar
• Narbutt J, Olejniczak I, Sobolewska-Sztychny D, et al. Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients. Arch Dermatol Res. 2013;305:191–195.
   PubMed Web of Science ®Google Scholar
• Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs. 2006;18:227–233.
   PubMedGoogle Scholar
• Evers AW, Kleinpenning MM, Smits T, et al. Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy. Br J Dermatol. 2009;161:542–546.
   PubMed Web of Science ®Google Scholar
• Théréné C, Brenaut E, Barnetche T, et al. Efficacy of systemic treatments of psoriasis on pruritus: A systemic literature review and meta-analysis. J Invest Dermatol. 2018;138:38–45.
   PubMed Web of Science ®Google Scholar
• Domagała A, Szepietowski J, Reich A. Antihistamines in the treatment of pruritus in psoriasis. Postepy Dermatol Alergol. 2017;34:457–463.
   PubMed Web of Science ®Google Scholar
• D’Erme AM, Zanieri F, Campolmi E, et al. Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study. J Eur Acad Dermatol Venereol. 2014;28:246–249.
   PubMed Web of Science ®Google Scholar
• Chang Y‐S, Chiang B‐L. Mechanism of sleep disturbance in children with atopic dermatitis and the role of the circadian rhythm and melatonin. Int J Mol Sci. 2016;17:462.
   PubMed Web of Science ®Google Scholar
• Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol. 1993;29:438–442.
   PubMed Web of Science ®Google Scholar
• Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol. 1994;46:517–522.
   PubMed Web of Science ®Google Scholar
• Roblin D, Yosipovitch G, Boyce B, et al. Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from experimental studies, and efficacy and safety of CT327 in a phase 2b clinical trial in patients with psoriasis. Acta Derm Venerol. 2015;95:542–548.
   PubMed Web of Science ®Google Scholar
• Kittaka H, Tominaga M. The molecular and cellular mechanisms of itch and the involvement of TRP channels in the peripheral sensory nervous system and skin. Allergol Int. 2017;66:22–30.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Hiura A. Four possible itching pathways related to the TRPV1 channel, histamine, PAR-2 and serotonin. Malays J Med Sci. 2013;20:5–12.
   PubMedGoogle Scholar
• Sakai K, Sanders KM, Youssef MR, et al. Mouse model of imiquimod-induced psoriatic itch. Pain. 2016;157:2536–2543.
   PubMed Web of Science ®Google Scholar